These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 20739041

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Assessment of hyper- and hypodopaminergic behaviors in Parkinson's disease].
    Ardouin C, Chéreau I, Llorca PM, Lhommée E, Durif F, Pollak P, Krack P, groupe évaluation comportementale de la maladie de Parkinson.
    Rev Neurol (Paris); 2009 Nov; 165(11):845-56. PubMed ID: 19683776
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Behavioral disorders in Parkinson's disease. Genetic, pharmacological and medico-legal aspects].
    Sobrido MJ, Dias-Silva JJ, Quintáns B.
    Rev Neurol; 2009 Jan 23; 48 Suppl 1():S43-8. PubMed ID: 19222015
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Treatment of parkinsonism and legal capacity].
    Wallesch CW.
    Fortschr Neurol Psychiatr; 2011 Aug 23; 79(8):441. PubMed ID: 21809256
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Dopamine dysregulation syndrome, addiction and behavioral changes in Parkinson's disease.
    Merims D, Giladi N.
    Parkinsonism Relat Disord; 2008 Aug 23; 14(4):273-80. PubMed ID: 17988927
    [Abstract] [Full Text] [Related]

  • 12. Drug therapy for Parkinson's disease.
    Hermanowicz N.
    Semin Neurol; 2007 Apr 23; 27(2):97-105. PubMed ID: 17390254
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Peak-dose dyskinesia; an acceptable price for mobility in late-stage Parkinson's disease?
    Wenzelburger R.
    Clin Neurophysiol; 2005 Sep 23; 116(9):1997-8. PubMed ID: 16055380
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Punding in Parkinson's disease.
    O'Sullivan SS, Evans AH, Lees AJ.
    Pract Neurol; 2007 Nov 23; 7(6):397-9. PubMed ID: 18024780
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A case of hedonistic homeostatic dysregulation.
    Kessel BL.
    Age Ageing; 2006 Sep 23; 35(5):540-1. PubMed ID: 16799178
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.